Drawing for TRYCERA

USPTO serial 97074318

TRYCERA

Reviewed by CopyMark Law Group

Reg. 7058571Status 700Registered
Filing date
Status date
Registration date
May 23, 2023
Examiner
WANG, YUAN YUAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TRYCERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
001antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; Biological and biotechnological products used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations; Biological preparations, namely, antibodies and fragments of antibodies for clinical or medical laboratory use and not for use in connection with pesticides for agricultural and horticultural use; biological preparations, namely, antibodies and fragments of antibodies for diagnostic use other than medical useACTIVE—
005auxiliary agents, carriers and substances for pharmaceutical preparations in the nature of antibodies sold as component ingredients of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosisACTIVE—
042Scientific, biological, pharmaceutical and medical research and development services in the field of antibodies not for use in connection with pesticides for agricultural and horticultural use; laboratory research in the field of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology not for use in connection with pesticides for agricultural and horticultural use; chemical, biochemical and biotechnological analysis and research services not for use in connection with pesticides for agricultural and horticultural useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 21, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 21, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 21, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 21, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 21, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 23, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 23, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 7, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 7, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 31, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 31, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jan 31, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 31, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 31, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 3, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 3, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 3, 2023ALIEASSIGNED TO LIE—
Dec 27, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2022DOCKASSIGNED TO EXAMINER—
Nov 9, 2021AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Nov 8, 2021ALIEASSIGNED TO LIE—
Nov 3, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2021PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 18, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance